FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45...

  • U.S. Food and Drug Administration
  • September 2, 2026
  • ID: D-0784-2026

Drug Enforcement Report Details

Recall NumberD-0784-2026
Recalling FirmACCORD HEALTHCARE, INC.
ClassificationClass II
Voluntary / MandatedVoluntary: Firm initiated
Distribution PatternNationwide within the United States
StatusOngoing
Product Description

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Reason for Recall

Subpotent Drug

Code Information

a) Lot #: D2402642, Exp. Date 11/30/2026 b) Lot #: D2401832, Exp. Date 08/31/2026; D2402525, D2402527, D2402526, D2402644, D2402643, Exp. Date 11/30/2026.


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.